Semnur Pharmaceuticals, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Semnur Pharmaceuticals, Inc. payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. payments for repurchase of common stock for fiscal 2024 was $43.43M, a 7.13% increase from fiscal 2023.
- Semnur Pharmaceuticals, Inc. payments for repurchase of common stock for fiscal 2023 was $40.54M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $43.43M 10-K · filed 2025-04-02 |
| 2023-12-31 | $40.54M 10-K · filed 2025-04-02 |